Literature DB >> 7068837

Selective medium for isolation of Actinobacillus actinomycetemcomitans.

J Slots.   

Abstract

A selective medium, TSBV (tryptic soy-serum-bacitracin-vancomycin) agar, was developed for the isolation of Actinobacillus actinomycetemcomitans, TSBV agar contained (per liter) 40 g of tryptic soy agar, 1 g of yeast extract, 100 ml of horse serum. 75 mg of bacitracin, and 5 mg of vancomycin. The TSBV medium suppressed most oral species and permitted significantly higher recovery of A. actinomycetemcomitans than nonselective blood agar medium. The distinct colonial morphology and positive catalase reaction of A. actinomycetemcomitans easily distinguished this bacterium from Haemophilus aphrophilus, Capnocytophaga species, and a few other contaminating organisms. With the TSBV medium, even modestly equipped laboratories will be able to isolate and identify A. actinomycetemcomitans from clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068837      PMCID: PMC272154          DOI: 10.1128/jcm.15.4.606-609.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism.

Authors:  C C Tsai; W P McArthur; P C Baehni; B F Hammond; N S Taichman
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Haemophili and related bacteria in the human oral cavity.

Authors:  M Kilian; C R Schiott
Journal:  Arch Oral Biol       Date:  1975-12       Impact factor: 2.633

3.  A selective method for the isolation of Haemophilus in material from the respiratory tract.

Authors:  B Hovig; E H Aandahl
Journal:  Acta Pathol Microbiol Scand       Date:  1969

4.  Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism.

Authors:  P Baehni; C C Tsai; W P McArthur; B F Hammond; N S Taichman
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation.

Authors:  J Slots; H S Reynolds; R J Genco
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

6.  Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans.

Authors:  N S Taichman; R T Dean; C J Sanderson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

7.  Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27.

Authors:  P Kiley; S C Holt
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

  7 in total
  73 in total

1.  Improved, low-cost selective culture medium for Actinobacillus actinomycetemcomitans.

Authors:  M Alsina; E Olle; J Frias
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

3.  Intra-oral colonization of macaque monkeys by Actinobacillus actinomycetemcomitans.

Authors:  D Beighton; N S Taichman; D L Simpson; J M Dirienzo; N W Johnson
Journal:  Oral Microbiol Immunol       Date:  1989-03

4.  Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

5.  Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.

Authors:  R Piccolomini; G Catamo; G Di Bonaventura
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

6.  Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure.

Authors:  L C Bueno; M P Mayer; J M DiRienzo
Journal:  J Periodontol       Date:  1998-09       Impact factor: 6.993

7.  Characterization of serologically nontypeable Actinobacillus actinomycetemcomitans isolates.

Authors:  S Paju; M Saarela; S Alaluusua; P Fives-Taylor; S Asikainen
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

8.  Evaluation of two commercial kits and arbitrarily primed PCR for identification and differentiation of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, and Haemophilus paraphrophilus.

Authors:  B Doğan; S Asikainen; H Jousimies-Somer
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Relationship between hydroxy fatty acids and prostaglandin E2 in gingival tissue.

Authors:  F Nichols; B Maraj
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Endarteritis and mycotic aortic aneurysm caused by an oral strain of Actinobacillus actinomycetemcomitans.

Authors:  M C Martín; M T Andrés; J F Fierro; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.